VERAPAMIL HYDROCHLORIDE
Generic: VERAPAMIL HYDROCHLORIDE
Actavis PharmaManufacturer
ORALRoute
VERAPAMIL HYDROCHLORIDEActive Substance
1986-10-01Original Approval
VERAPAMIL HYDROCHLORIDE is FDA application ANDA070995, sponsored by WATSON LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2024-07-02
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial Cross contamination with other products.
Class III2024-07-02
Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, ManufacturCross contamination with other products.
Class II2021-03-15
Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462-292-01 Manufactured by: Glenmark Generics CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class III2023-08-14
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, ManufacturedSubpotent: Out of Specification for Assay Test at the 3-month time point.
Top Reported Reactions
1
DYSPNOEA
353 reports
2
NAUSEA
351 reports
3
DRUG INTERACTION
317 reports
4
DIZZINESS
295 reports
5
HYPOTENSION
293 reports
6
FATIGUE
275 reports
7
DIARRHOEA
271 reports
8
COMPLETED SUICIDE
247 reports
9
VOMITING
246 reports
10
ABDOMINAL PAIN
243 reports